Evaluation of Prognostic Factors and Role of Participation in a Randomized Trial or a Prospective Registry in Pediatric and Adolescent Nonmetastatic Medulloblastoma – A Report From the HIT 2000 TrialStefan Dietzsch, Martin Mynarek, Jutta Welzel et al.|Advances in Radiation Oncology|2020Cited by 22
Pretreatment central quality control for craniospinal irradiation in non-metastatic medulloblastomaStefan Dietzsch, Rolf‐Dieter Kortmann, Annett Braesigk et al.|Strahlentherapie und Onkologie|2020Cited by 21
Types of deviation and review criteria in pretreatment central quality control of tumor bed boost in medulloblastoma—an analysis of the German Radiotherapy Quality Control Panel in the SIOP PNET5 MB trialStefan Dietzsch, Rolf‐Dieter Kortmann, Annett Braesigk et al.|Strahlentherapie und Onkologie|2021Cited by 12
MBCL-11. TIME TO RADIOTHERAPY IMPACTS SURVIVAL IN PEDIATRIC AND ADOLESCENT NON-METASTATIC MEDULLOBLASTOMA TREATED BY UPFRONT RADIOTHERAPY – A REPORT FROM THE HIT 2000 TRIALStefan Dietzsch, Martin Mynarek, Felix Placzek et al.|Neuro-Oncology|2020Cited by 0